Total Voting Rights

RNS Number : 6126Y
Avacta Group PLC
10 September 2015
 



 

10 September 2015


Avacta Group plc

 

("Avacta", the "Company" or the "Group")

 

Total Voting Rights

 

The Company would like to confirm that Avacta's issued share capital consists of 6,740,649,550 Ordinary Shares of 0.1p each with voting rights, and not 6,740,149,550 as was incorrectly stated in the Company's announcement on 3 September 2015.

 

The above figure of 6,740,649,550 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules. The Company does not hold any shares in Treasury.

 

- Ends -

 

For further information:

 

Avacta Group plc

Tim Sykes, Chief Financial Officer

Tel:  +44 (0) 844 414 0452

www.avacta.com

 

Numis Securities Limited    

Michael Meade / Freddie Barnfield - Nominated Adviser

James Black - Corporate Broking

 

Tel:  +44 (0) 207 260 1000

www.numiscorp.com

 

Media Enquiries

FTI Consulting

Simon Conway/Natalie Garland-Collins

 

Tel: +44 (0) 20 3727 1000

avacta@fticonsulting.com

 

About Avacta Group plc - www.avacta.com

 

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through two divisions:

 

Avacta Animal Health

www.avactaanimalhealth.com

Veterinary diagnostics reference laboratory and diagnostic kit provider.

 

Avacta Life Sciences

www.avactalifesciences.com

 

Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRLKLLBEKFLBBV
UK 100

Latest directors dealings